Connected Care and Remote Patient Monitoring: Payer-Side Realities

Connected devices create value for a health plan only when four things work together: a clinically valid, billable signal; a triage layer that protects care-team time; sustained member engagement; and evidence that the spending is offset by avoided utilization. Devices alone solve none of them.Six findings follow from the payer's side of the table:1. Reimbursement is provider revenue and plan cost. Remote patient monitoring (RPM) codes pay the practice that bills them. For a Medicare Advantage or Medicaid plan, each fully engaged member is a monthly expense that must be recovered through avoided utilization or measurable quality gains.2. The 2026 codes lower the engagement bar but not the billing conditions. Two new Medicare codes, CPT 99445 (2 to 15 days of data) and CPT 99470 (first 10 minutes of management), let programs bill in lower-engagement months. Medical necessity, documented monitoring days and interactive communication still apply.3. Signal quality and alert volume, not data supply, are the bottleneck. Wearables produce more readings than any care team can review. Plans pay for noise unless artifacts are filtered and only clinically meaningful events escalate.4. Engagement is the hidden cost driver, especially on constrained devices. Members with limited data plans, shared phones or low digital literacy transmit less, which cuts both clinical value and billable days. Low-data, offline-first design and caregiver-assisted onboarding are requirements, not extras.5. A sensor's regulatory status decides what it can support. Features marketed as wellness differ from FDA-cleared ones, and that difference matters for billing, liability and plan contracts.6. Evidence comes first, then coverage. Coverage for continuous glucose monitoring followed years of outcomes evidence, including randomized trials. Connected care programs need payer-grade evidence on utilization and quality measures, and AI triage needs governance that continues after go-live.